Price Transparency Hospital negotiated rates

Hospital facility prices. What the hospital charges for the facility side of care — the surgeon’s and anesthesiologist’s fees are billed separately and are not included. How we scope prices →

Export CSV

GRANDE RONDE HOSPITAL

La Grande, OR · CCN 381321 · Rates published

3,421 distinct procedures filed
11 distinct payers
102,472 rate rows
2025-02-06 last MRF observed · ⚠ 16 mo old

102,420 of 102,472 rate rows are consumer-grade (99.9%)

52 rows are marked excluded from the consumer medians — these stay visible in the raw drill-down with the same reason shown here, so nothing is silently hidden.

Excluded — reasonRows
per-diem day rate — not a per-procedure price 30
percent-of-charges filed in the dollar field — excluded from medians 12
placeholder amount (≤ $0.02) — excluded from medians 8
exceeds 10× this hospital's gross charge — excluded from medians 2

⚠ Possibly outdated The most recent machine-readable file we have for this hospital is 16 months old. CMS requires hospitals to refresh these files at least annually, so newer rates may exist that we haven't ingested yet. The prices below are exactly as last filed.

↓ Download audit trail (JSON)
Source MRF file https://www.grh.org/clientfiles/GetFile/930505325_grande-ronde-hospital_standardcharges.csv
Found on page https://www.grh.org/patients-visitors/price-transparency/
Discovered viaCMS hospital list
Last fetch not_modified · 2026-05-19
Content fingerprint b7c71e20344cfa74… · 71,676,408 bytes · first seen 2026-05-15

Top 50 most expensive offerings

Outliers are flagged where this hospital's filed rate is ≥2× or ≤0.5× the national median for the same code.

Code Description Payers Min $ Max $ Avg median vs national
J9347
HCPCS
Tremelimumab-actl 300 Mg/15ml IV Soln 11 $46,388.64 $102,055.00 $96,900.71 nat. median
$3,461

outlier · 28.0×
J9298
HCPCS
Nivolumab-relatlimab-rmbw 240-80 Mg/20ml IV Soln 11 $34,591.41 $76,101.10 $72,257.61 nat. median
$562

outlier · 128.7×
J9043
HCPCS
Cabazitaxel 60 Mg/1.5ml IV Soln 11 $16,547.44 $36,404.37 $34,565.76 nat. median
$739

outlier · 46.8×
J2350
HCPCS
Ocrelizumab 300 Mg/10ml IV Soln 11 $13,115.02 $28,853.04 $27,395.81 nat. median
$712

outlier · 38.5×
J9022
HCPCS
Atezolizumab 1200 Mg/20ml IV Soln 11 $12,796.04 $28,151.29 $26,729.51 nat. median
$6,951

outlier · 3.8×
J9119
HCPCS
Cemiplimab-rwlc 350 Mg/7ml IV Soln 11 $12,066.96 $26,547.31 $25,206.53 nat. median
$91

outlier · 276.2×
J9144
HCPCS
Daratumumab-hyaluronidase-fihj 1800-30000 Mg-ut/15ml Subq Soln 11 $11,306.52 $24,874.35 $23,618.08 nat. median
$233

outlier · 101.3×
J9042
HCPCS
Brentuximab Vedotin 50 Mg IV Solr 11 $10,471.13 $23,036.48 $21,873.02 nat. median
$1,050

outlier · 20.8×
J9228
HCPCS
Ipilimumab 50 Mg/10ml IV Soln 11 $10,210.51 $22,463.12 $21,328.62 nat. median
$9,906

outlier · 2.2×
J3380
HCPCS
Vedolizumab 300 Mg IV Solr 11 $10,167.95 $22,369.50 $21,239.72 nat. median
$288

outlier · 73.7×
J9301
HCPCS
Obinutuzumab 1000 Mg/40ml IV Soln 11 $9,673.50 $21,281.70 $20,206.87 nat. median
$314

outlier · 64.4×
J9223
HCPCS
Lurbinectedin 4 Mg IV Solr 11 $9,426.87 $20,739.12 $19,691.69 nat. median
$627

outlier · 31.4×
J9307
HCPCS
Pralatrexate 20 Mg/ml IV Soln 11 $8,370.71 $36,657.83 $18,136.53 nat. median
$827

outlier · 21.9×
J0135
HCPCS
Adalimumab 80 Mg/0.8ml Subq Ajkt 11 $7,504.36 $16,509.59 $15,675.77 nat. median
$3,851

outlier · 4.1×
J9063
HCPCS
Mirvetuximab Soravtansine-gynx 100 Mg/20ml IV Soln 11 $7,319.76 $16,103.48 $15,290.17 nat. median
$214

outlier · 71.3×
J9271
HCPCS
Pembrolizumab 100 Mg/4ml IV Soln 11 $6,677.95 $14,691.48 $13,949.49 nat. median
$736

outlier · 18.9×
J2327
HCPCS
Risankizumab-rzaa 600 Mg/10ml IV Soln 11 $5,715.56 $12,574.24 $11,939.17 nat. median
$2,241

outlier · 5.3×
J2323
HCPCS
Natalizumab 300 Mg/15ml IV Conc 11 $5,548.06 $12,205.74 $11,589.29 nat. median
$201

outlier · 57.7×
J2506
HCPCS
Pegfilgrastim 6 Mg/0.6ml Subq Sosy 11 $4,668.67 $10,271.08 $9,752.34 nat. median
$2,076

outlier · 4.7×
PX-36010153
CDM
Hc Operating Room Services Level 8 1st 30 Mins 11 $4,442.31 $9,773.08 $9,279.49 nat. median
$3,184

outlier · 2.9×
J9311
HCPCS
Rituximab-hyaluronidase Human 1400-23400 Mg -ut/11.7ml Subq Soln 11 $4,423.75 $9,732.25 $9,240.73 nat. median
$1,507

outlier · 6.1×
J1950
HCPCS
Leuprolide Acetate (3 Month) 11.25 Mg IM Kit 11 $1,679.74 $26,695.83 $8,996.05 nat. median
$4,345

outlier · 2.1×
J9061
HCPCS
Amivantamab-vmjw 350 Mg/7ml IV Soln 11 $4,301.15 $9,462.54 $8,984.63 nat. median
$63

outlier · 142.1×
J9332
HCPCS
Efgartigimod Alfa-fcab 400 Mg/20ml IV Soln 11 $4,082.85 $8,982.26 $8,528.61 nat. median
$112

outlier · 75.8×
J9047
HCPCS
Carfilzomib 60 Mg IV Solr 11 $3,868.67 $8,511.08 $8,081.23 nat. median
$1,668

outlier · 4.8×
J9299
HCPCS
Nivolumab 100 Mg/10ml IV Soln 11 $1,754.21 $19,726.59 $8,062.07 nat. median
$2,947

outlier · 2.7×
PX-36010152
CDM
Hc Operating Room Services Level 7 1st 30 Mins 11 $3,848.53 $8,466.78 $8,039.16 nat. median
$3,184

outlier · 2.5×
J0491
HCPCS
Anifrolumab-fnia 300 Mg/2ml IV Soln 11 $3,518.92 $7,741.63 $7,350.64 nat. median
$54

outlier · 136.4×
J0517
HCPCS
Benralizumab 30 Mg/ml Subq Soaj 11 $3,380.94 $8,402.68 $7,175.10 nat. median
$919

outlier · 7.8×
J9205
HCPCS
Irinotecan Hcl Liposome 43 Mg/10ml IV Inj 11 $3,356.62 $7,384.57 $7,011.61 nat. median
$207

outlier · 33.9×
J2427
HCPCS
Paliperidone Palmitate ER 410 Mg/1.32ml IM Susy 11 $3,183.30 $13,965.43 $7,003.27 nat. median
$4,091

1.7× median
J9145
HCPCS
Daratumumab 400 Mg/20ml IV Soln 11 $3,351.23 $7,372.71 $7,000.35 nat. median
$438

outlier · 16.0×
J7169
HCPCS
Coag Fact Xa Inactivated-zhzo 200 Mg IV Solr 11 $3,348.09 $7,365.79 $6,993.78 nat. median
$281

outlier · 24.9×
J9358
HCPCS
Fam-trastuzumab Deruxtec-nxki 100 Mg IV Solr 11 $3,325.62 $7,316.36 $6,946.84 nat. median
$110

outlier · 63.4×
J0896
HCPCS
Luspatercept-aamt 25 Mg Subq Solr 11 $2,661.97 $17,539.22 $6,914.35 nat. median
$4,612

1.5× median
PX-36010151
CDM
Hc Operating Room Services Level 6 1st 30 Mins 11 $3,267.95 $7,189.48 $6,826.37 nat. median
$3,184

outlier · 2.1×
G0235
HCPCS
Hc PET Not Otherwise Specified 11 $3,143.93 $6,916.64 $6,567.31 nat. median
$628

outlier · 10.5×
G0252
HCPCS
Hc PET Imaging Initial Dx Breast 11 $3,143.93 $6,916.64 $6,567.31 nat. median
$1,852

outlier · 3.5×
J9308
HCPCS
Ramucirumab 100 Mg/10ml IV Soln 11 $2,001.84 $18,828.44 $6,481.21 nat. median
$1,489

outlier · 4.4×
PX-36010150
CDM
Hc Operating Room Services Level 5 1st 30 Mins 11 $3,004.99 $6,610.97 $6,277.09 nat. median
$3,184

2.0× median
J1162
HCPCS
Digoxin Immune Fab 40 Mg IV Solr 11 $2,966.66 $6,526.65 $6,197.02 nat. median
$7,316

0.8× median
78815
CPT
Nuclear Medicine Study From Skull Base To Mid-thigh W/ct 11 $2,960.93 $6,514.05 $6,185.06 nat. median
$2,794

outlier · 2.2×
J2799
HCPCS
Risperidone ER 200 Mg/0.56ml Subq Susy 11 $2,956.36 $6,503.98 $6,175.50 nat. median
$78

outlier · 78.9×
J9317
HCPCS
Sacituzumab Govitecan-hziy 180 Mg IV Solr 11 $2,924.67 $6,434.28 $6,109.32 nat. median
$115

outlier · 53.3×
J0791
HCPCS
Crizanlizumab-tmca 100 Mg/10ml IV Soln 11 $2,911.85 $6,406.06 $6,082.52 nat. median
$342

outlier · 17.8×
J2356
HCPCS
Tezepelumab-ekko 210 Mg/1.91ml Subq Sosy 11 $2,801.04 $6,162.29 $5,851.07 nat. median
$66

outlier · 88.4×
J9177
HCPCS
Enfortumab Vedotin-ejfv 20 Mg IV Solr 11 $2,707.03 $8,871.29 $5,805.07 nat. median
$3,115

1.9× median
J9034
HCPCS
Bendamustine Hcl 100 Mg/4ml IV Soln 11 $2,739.36 $6,026.59 $5,722.22 nat. median
$111

outlier · 51.4×
J9176
HCPCS
Elotuzumab 300 Mg IV Solr 11 $2,653.51 $7,742.33 $5,690.31 nat. median
$2,586

outlier · 2.2×
PX-20610001
CDM
Hc Intensive Care Intermediate 8 $3,131.86 $5,741.75 $5,567.76 nat. median
$5,568

1.0× median

Other procedures at this hospital

Browse this hospital's 3,421 published procedures. Use the slice to choose what to show, then sort or filter any column.

Sortable, filterable data table. Use the column headers to sort, the filter row to narrow results.
Code Type Description Rate rows Payers Gross Cash Min $ Max $ Avg median Last observed
             
See an error in this hospital's data? Submit a correction